Burkon Wang

Burkon Wang is currently the Global Head of Strategy and Business Development at Leica Biosystems, where the focus is on advancing cancer diagnostics. Previously, Burkon served as the VP/General Manager of the Sanofi Genzyme Specialty Care Unit in China, overseeing the P&L and managing over 20 new product launches. Burkon's experience includes significant roles at Novartis, such as VP/Head of Strategy and New Launch, and leadership positions in the Ophthalmology Business Unit, where revenue doubled. In the early career, Burkon contributed as a consultant at McKinsey & Company and held positions at J.P. Morgan and Fremont Partners. Burkon holds a B.A. in Economics from Stanford University and an MBA from The Wharton School.